American Patients Will Bear the Cost of Government Price Controls

The 2024 Patient Access Report shows that up to 44% fewer medicines will be launched in the U.S. because of government price controls.

Related Keywords

Canada ,United States ,Germany ,South Korea ,Spain ,Australia ,Washington ,Americans ,American ,Brad Watts ,Us Chamber Patient Access ,European Union ,University Of Chicago ,Data Uncovers Alarming Impact ,Price Controls ,Patient Access Report ,Findings Expose Growing Threats ,American Patients ,Vital Transformation ,Patient Access Matrix ,